載入...
ANTIHYPERGLYCEMIC MEDICATION PRESCRIBING AND STATE MEDICAID PROGRAM RESPONSES TO ROSIGLITAZONE SAFETY WARNINGS
Medicaid programs use preferred drug lists to limit high-cost prescribing, but their effect on promoting more effective and safer prescribing is unknown. We examined the impact of the May 2007 rosiglitazone safety warnings on rosiglitazone availability on state Medicaid preferred drug list programs...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3319744/ https://ncbi.nlm.nih.gov/pubmed/22232110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1377/hlthaff.2011.1068 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|